Interojo Co

Interojo Co OCF Margin

The Operating Cash Flow Margin of Interojo Co (119610.KQ) as of Nov 20, 2026 is 21.39 %. In the previous year, Operating Cash Flow Margin was 17.08 % — a change of 25.28% (higher).

OCF Margin

21.39 %

YoY

25.28%

Last updated:

Operating Cash Flow Margin of Interojo Co is 2025 21.39 % . Operating Cash Flow Margin of Interojo Co was 2024 17.08 % . It decreases by 25.28% higher compared to the previous year.

The Interojo Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
11.58 KRW
Jan 1, 2019
25.42 KRW
Jan 1, 2020
19.32 KRW
Jan 1, 2021
11.84 KRW
Jan 1, 2022
9.49 KRW
Jan 1, 2023
6.99 KRW
Jan 1, 2024
17.08 KRW
Jan 1, 2025
21.39 KRW
The Interojo Co OCF Margin history
YEAROCF MarginYoY
21.39 %+25.28%
17.08 %+144.23%
6.99 %-26.33%
9.49 %-19.85%
11.84 %-38.70%
19.32 %-24.00%
25.42 %+119.56%
11.58 %-17.35%
14.01 %-31.75%
20.52 %-28.32%
28.63 %+58.97%
18.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Operating Cash Flow Margin of Interojo Co is 21.39 % in 2025.

Operating Cash Flow Margin of Interojo Co changed from 17.08 % to 21.39 %, representing a 25.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Interojo Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Interojo Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Interojo Co

All Key Metrics — Interojo Co